(1) For the purposes of this Part, MD&A means a completed Form 51-102F1 or, in the case of an SEC issuer, a completed Form 51-102F1 or management’s discussion and analysis prepared in accordance with Part 303 of Regulation S-K under the 1934 Act.
(b) must disregard
(i) the Instruction to section 1.11 of Form 51-102F1, and
(ii) section 1.15 of Form 51-102F1, and
(c) must include the disclosure required by section 1.10 of Form 51-102F1 in the prospectus.